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Nutritional status and muscle amino acids in children with end-stage
renal failure. Nutritional status, assessed by anthropometric and bio-
chemical methods, and muscle water, protein and amino acid compo-
sition, were evaluated in a control group of 10 children with normal
renal function who were undergoing elective surgery, and in 15 children
with end-stage chronic renal failure. Samples of the rectus abdominis
muscle were taken when surgery was performed in the control children
and when a peritoneal catheter was implanted in the uremic children.
Height and body weight were reduced in the uremic children compared
to the controls but skinfold thickness, arm muscle circumference and
serum proteins (total protein, albumin, transferrin, pseudocholinester-
ase) were essentially normal. The muscle contents of total, extracellular
and intracellular water, and of alkali-soluble protein (ASP), DNA and
the ASP-DNA ratio were not significantly different in uremic children
from those in the controls. Plasma leucine, isoleucine, tyrosine, valine,
and serine levels were significantly decreased, whereas plasma citrul-
line, 1-methylhistidine and 3-methylhistidine levels were increased.
Muscle isoleucine and valine levels and the valine/glycine ratio were
low in the uremic children. Our results demonstrate that children with
chronic renal failure and growth retardation may maintain a satisfactory
nutritional status but exhibit amino acid abnormalities typical of ure-
There are numerous reports concerning abnormal plasma
amino acid (AA) concentrations in patients with chronic renal
failure [1—3]. The plasma concentrations do not necessarily
reflect the intracellular concentrations, and the determination of
free AA in muscle, which is the largest pool of free AA in the
body, is of particular interest in the study of AA metabolism in
uremia. In untreated adult patients with chronic renal failure
(CRF) a typical muscle intracellular AA pattern has been
described [4, 5]. Intracellular AA abnormalities similar to those
in adult patients have also been reported in children with CRF
[6, 7]. The role of nutritional factors and of uremia itself in these
abnormalities is still not clear. The aim of this study was to
investigate plasma and muscle AA concentrations in relation to
anthropometric and biochemical nutritional parameters in chil-
dren with end-stage renal failure.
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Methods
Patients
Fifteen children with CRF (9 girls and 6 boys) with a mean
age of 8.9 4.6 years (range 1.3 to 15.5 years) were studied.
They all had a creatinine clearance <5 mI/mm/I .73 m2. None of
them had diabetes mellitus or a systemic disease. They showed
no evidence of chronic infection. They were treated with
diuretics, antihypertensive drugs, calcium carbonate, Shohl
solution, vitamin D analogs and supplements of water-soluble
vitamins (B vitamin and ascorbic acid). None of the children
were treated with corticosteroids, androgenic steroids, eryth-
ropoietin or growth hormone. They were prescribed a diet with
a protein content which was 75% and an energy content which
was 100% of the recommended daily allowance (RDA) for
statural age. The protein and energy intakes were estimated
from the dietary recall records which were taken over a
three-day period by a dietitian. The protein intake was also
estimated from the 24 hours urea excretion according to
Maroni, Steinman, Mitch [8]. The estimated protein intake
based on recall and urea excretion were in close agreement and
not significantly different from the estimated prescribed protein
intake (Table 1). The estimated energy intake was on average
94.8 11.8% of RDA (range 77 to 120%).
The control group comprised ten children (2 girls and 8 boys)
with a mean age of 8.8 3.1 years (range 2.7 to 13 years) who
were undergoing elective surgery for hernia correction or
uretero-pelvic junction stenosis. They were all in good health,
except for the minor disabilities which required elective sur-
gery, and had no signs of metabolic or renal disease.
In 13 patients anthropometric measurements were performed
including biceps, triceps and subscapular skinfold thickness.
Arm muscle circumference (AMC) was derived from the arm
circumference (AC) and the triceps skinfold (TSF) where AMC
= AC — - x TSF. The results were evaluated in relation to data
for children reported in the literature [9—11].
Venous blood and muscle samples for AA analyses were
obtained simultaneously after an overnight fast, both from the
patients and the controls. The muscle biopsy specimens were
taken from the rectus abdomini muscle when the peritoneal
catheter was implanted in the uremic children, and during
elective surgery in the controls.
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Table 1. Patients characteristics, protein and energy intake, and serum biochemistries in 15 children with chronic renal failure
Patient Sex
Age
years
Height
cm
Body
weight
kg
Protein intake
Serum
creatinine
.irnol/liter
Blood
urea
mmol/liter
.Creatinine
clearance
mi/mini! .73 m2
Serum
albumin
giliter
Prescribed
glkg/body wt
Estimated from
Recall UV urea
g/kg/body wt gikg/body wt
I
2
3
4
5
6
7
8
9
10
11
12
13
14
IS
F
M
F
F
M
F
M
M
M
F
F
F
M
F
F
8.1
8.9
3.5
12.9
8.1
15.1
1.3
7.8
5.6
15.0
15.5
6.6
2.6
11.6
11.5
112
Ill
85
140
119.5
136
67.5
84
107
143
131.5
111
90
126
141.5
22
18.7
11.6
22.5
25.4
29.8
6.5
12.2
16.8
38.2
32.0
19.5
11.6
34.1
42
1.00
1.10
1.30
0.90
0.90
1.00
1.60
1.15
1.10
0.90
0.85
0.90
1.30
0.90
1.00
1.12 1.20
1.14 0.89
1.43
0.98 1.03
1.00
0.95 1.10
1.78
1.25
1.25
0.88 0.75
0.95 0.90
0.99 0.78
1.50
0.94 1.03
1.09 1.09
879
940
615
888
896
668
308
580
1019
1090
905
844
378
747
1186
16.0
28.3
31.6
40.2
29.6
54.1
21.4
26.8
38.4
53.1
37.3
27.6
20.8
36.3
43.0
4.0
3.0
3.3
5.0
5.0
5.3
5.2
4.7
2.0
5.0
3.0
5.0
4.5
5.0
2.0
41.5
34.7
36.0
47.1
42.9
38.0
53.0
35.0
48.0
48.0
49.0
34.4
38.0
52.0
56.0
Mean
SD
8.9
4.6
113.2
21.3
22.9
10.6
1.06
0.21
1.15 0.97
0.25 0.15
796
248
33.6
11.1
4.13
1.17
43.6
7.3
Parental consent was given before the children were admitted
to this study.
Analytical procedures
Serum urea, creatinine, bicarbonate, total protein and albu-
min levels were determined by routine methods. A heparinized
blood sample was centrifuged at 4000 rpm for 10 minutes at
+4°C to obtain plasma which was then deproteinized with
sulfosalicylic acid and centrifuged. The supernatant was stored
at —70°C until AA analyses were performed.
The muscle specimen was carefully and rapidly dissected to
remove visible fat and connective tissue. The specimen was
weighed repeatedly on a Cahn electromagnetic balance and the
initial wet weight was calculated by extrapolating the weight
curve to zero time. Immediately after weighing, the specimen
was frozen in liquid nitrogen. The frozen material was placed in
sodium-free glass tubes which had previously been rinsed with
nitric acid (1 mol/liter), freeze-dried and reweighed. The dried,
fat-extracted specimen was powdered in an agate mortar and
carefully dissected under a magnifying glass to remove remain-
ing flakes of connective tissue, About 2.5 mg of the powder
used for chloride analysis was dried at 80°C for 30 minutes. This
procedure reduced the water content by approximately 5%.
Chloride was extracted using 1 M nitric acid (1 mol/liter) and
determined by electrometric titration, as described earlier [12,
13]. The true dry weight of the remaining powder was calcu-
lated as 95% of the observed weight after powdering at room
temperature and humidity. Alkali-soluble protein (ASP) that is,
non-collagen protein, and DNA were determined in 3 to 4 mg of
the powder after precipitation with 4% sulfosalicylic acid. The
precipitate was incubated for one hour in KOH (0.3 mol/liter)
and ASP was determined in an aliquot using the Lowry method
[141. DNA analysis of the residues was based on the Schmidt-
Tannhauser technique [15]. For DNA extraction the precipitate
was hydrolyzed by adding 0.25 ml perchloric acid (1
mol liter I) and incubated for one hour at 70°C. The tube was
weighed again to obtain a dilution volume for DNA. DNA was
estimated by the diphenylamine reaction [16].
Muscle and plasma free AA were analyzed in the superna-
tants after sulfosalicylic acid precipitation by reversed phase
HPLC (Beckman Instruments, Fullerton, California, USA),
using pre-column derivatization with orthophthaldialdehyde
and an internal standard (homoserine) as described earlier [17,
18]. Taurine, alanine, 1-methylhistidine (1 M-HIS) and 3-meth-
ylhistidine (3 M-HIS) coeluted in the muscle and in some of the
plasma samples. The combined concentrations of these pairs of
AA are presented in the tables and were used to calculate the
sum of AA.
The calculations of extra- and intracellular water and intra-
cellular AA concentrations in muscle, which are based on the
chloride method, have been described earlier [19]. Total, extra-
and intracellular water, fat, DNA and ASP are expressed per kg
of fat-free solids (FFS). The ASP/DNA ratio is presented as an
indicator of the amount of cell protein per cell unit.
Statistical analysis of the data was carried out with the
Student's t-test.
Results
Height and weight (Table 2) were lower in the uremic children
than in controls but the weight for height index was not
significantly different from normal. The subscapular and biceps
skinfold thicknesses and the arm muscle circumferences in the
uremic children (Fig. 1) varied from the 5th to the > 75th
percentiles for height and age.
Serum proteins (total protein, albumin, transferrin and pseu-
docholinesterase), blood lymphocyte count, serum bicarbon-
ate, muscle ASP and ASP/DNA ratio were not significantly
different in the uremic children compared to the controls (Table
2, Fig. 2). Taken together the anthropometric and biochemical
data indicate that the uremic children were not suffering from
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Controls
(N= 10)
CRF
(N= 15)
Height (SDS)
Weight (SDS)
0.7 1.3
1.01 1.55
—2.87 1,8b
—1.57 1,38b
WHI 1.09 0.14 1.0 0.15
Plasma protein giliter 72.1 7.5 69 10
Plasma albumin giliter 46.0 4.5 43.6 7.3
Plasma transferrin mg/liter 3.68 0,69 3.32 0.69
Pseudocholinesterase U.I.iliter 5140 687 4895 1341
Blood lymphocytes count/mm 2133 462 1903 541
Hemoglobin g/dl 14.2 0.8 8 l.6
Serum bicarbonate mmoi/liter" 23.0 2.0 24.3 4.03
ASP g/kgffs 721 22 703 26
DNA g/kg ifs 1.86 0.38 1.78 0.44
ASP/DNA gig 401 71 420 113
Total water mi/kg ifs 3284 204 3259 292
Extracellular water mi/kg ifs 754 304 761 396
Intracellular water mi/kg ifs 2539 189 2499 437
Values are means SD. Abbreviations are: SDS. standard deviation
score; WHI, weight for height index (observed weight/ideal weight for
the height); ifs, fat free solids.
a Obtained a few days before the muscle biopsyb p < 0.05
P < 0.001
protein-energy malnutrition. Only two children had slight aci-
dosis (serum bicarbonate 20.0 and 20.6 mmol/liter, respective-
ly).
Total water, extracellular water and intracellular water in
muscle were also normal in the uremic children (Table 2).
Plasma and muscle intracellular amino acid concentrations in
the children with CRF and in the controls are presented in
Tables 3 and 4. The concentrations of amino acids in percentage
of controls are given in Figures 3 and 4.
The plasma concentrations of serine and most of the essential
AA (Table 3, Fig. 3) were significantly lower in the uremic
children than in the controls. The plasma levels of citrulline and
I M-HIS and 3 M-HIS were significantly increased. The intra-
cellular concentrations of VAL and ILE in muscle were signif-
icantly lower than in the controls (Table 4, Fig. 4). Among the
non-essential AA only 1 M-HIS, 3 M-HIS and glycine showed
increased intracellular concentrations. The intracellular/extra-
cellular gradient for the AA in the uremic children was not
significantly different from that in the controls.
The ratio of tyrosine to phenylalanine was significantly
decreased in plasma whereas the ratio of glycine to serine was
significantly increased (Table 3). In muscle the ratio of valine to
glycine was significantly decreased whereas the ratio of glycine
to serine was significantly increased (Table 4).
Discussion
The methods for processing muscle samples which were used
in this study make it possible to determine several different
constituents in one muscle specimen. Various tissue compo-
nents are usually evaluated in relation to one another, and some
of them serve as references and represent the cell mass or the
number of cell units in the sample. Hence, by performing the
analyses on aliquots from the same muscle specimen, sampling
variability can be minimized, The ability to perform many
Fig, 1. Skinfold thicknesses and arm muscle circumferences in 13 of
the children with chronic rena/failure (CRF, expressed as percentiles
in comparison to material from the literature [9—11]. Symbols are (U)
triceps; () subscapular.
Table 2. Anthropometric measurements, serum and muscle
biochemistries in children with chronic renal failure (CRF) and
controls
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Cl)
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ci)
E
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0
ci)
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4
3
2
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0
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5—9 10—24 25—49 50—74 : 75
Percentile
different determinations in one small muscle sample is of special
value in studies of small children.
The uremic children in this study were all in end-stage renal
failure and about to start CAPD, but none was in need of acute
dialysis. The anthropometric data, except height and weight did
not differ significantly from those in the control group. This
shows that the nutritional status was satisfactory, although
these children had a lower protein intake than RDA for statural
age.
There was a linear correlation between the ASP/DNA ratio in
muscle and age, and no difference between the controls and the
uremic children (Fig. 2). Thus the intracellular protein content
"per unit cell" increases with the maturation of the individual,
presumably because of an age-dependent increase in cell size.
The normal ASP/DNA ratio for age in the children with CRF is
further evidence that they did not suffer from protein malnutri-
tion.
The uremic children, although not malnourished, were all
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growth retarded, which indicates that factors other than mal-
nutrition are involved in the pathogenesis of this finding.
In a previous study, children who were uremic or on main-
tenance hemodialysis were reported to show marked protein
depletion, as assessed by muscle ASP that was so low in
relation to FFS, potassium, phosphate and low serum transfer-
nfl levels [201. The authors suggested that the protein depletion
resulted chiefly from an inadequate protein intake.
The fact that ASP was normal in our CRF patients, not only
in relation to FFS but also to DNA, which is a more reliable
basis of reference, suggests that the nutritional status was far
better maintained in our patients than in the patients described
by Delaporte et al. The reason for this is not obvious, but the
lower intake of protein in Delaporte's patients (65% of RDA)
compared to 75% in our patients may have been partly respon-
sible for this difference, Moreover, it cannot be ruled out that
variations in compliance with the prescribed diets between the
two groups of patients as much as differences in methodology
may have played a role.
Most studies in adult patients with CRF have shown that the
total and extracellular water levels in muscle are increased [13].
It is therefore of interest that the children with CRF in this
study had no increase in total and extracellular water, although
they were in such an advanced stage of renal failure that dialysis
had to be started very soon. It is obvious that even in severely
uremic children tissue overhydration can be prevented by
careful conservative therapy.
In the present study, muscle samples were taken from the
rectus abdominis muscle and plasma and muscle AA were
determined by HPLC, whereas in earlier studies of healthy
controls and uremic patients samples were taken from the
quadriceps femoris muscle and the AA were determined by ion
exchange chromatography. In spite of these differences in
methodology, the plasma and muscle levels of most AA in the
controls were similar to those reported previously [5]. Com-
pared to the controls the uremic patients had several significant
AA abnormalities in plasma and muscle, although they had no
Table 3. Plasma free amino acids mol/liter
Controls CRF
(N= 10) (N= 15)
Essential
Histidine 68 12 57 17
Isoleucine 66 21 49 l3
Leucine 120 35 81
Lysine 97 33 92 30
Methionine 42 14 49 20
Phenylalanine 43 8 43 11
Threonine 92 27 72 27
Tyrosine 41 7 28 10b
Valine 199 47 145
Non-essential
Arginine 47 14 48 23
Asparagine 38 7 35 13
Aspartic acid 3 1 3.9 3.7
Citrulline 26 8 70 27c
Glutamic acid 55 1 60 29
Glutamine 831 158 582 356
Glycine 179 43 215 121
Ornithine 34 9 32 10
Serine 100 21 77 23
1-Methyihistidine + 3-methylhistidine 17 7 l23 58C
Alanine + taurine 235 45 268 122
Ratios
Valine/Glycine 1.26 0.79 0.87 0.56
Glycine/Serine 1.79 0.19 2.71 0,87b
Tyrosine/Phenylalanine 0.97 0.17 0.65 0.19
EAA/NEAA 0.50 0.13 0.44 0.14
Total 2324 237 2099 670
EAA 762 102 595 120b
NEAA 1563 238 1505 634
BCAA 382 101 275 77"
clinical, anthropometric or laboratory signs of protein malnu-
trition.
Our observations of low branched-chain AA (BCAA) levels
in plasma and low isoleucine and valine concentrations in
muscle are in keeping with results in adults and children in
different stages of chronic renal failure [3—7]. In adult patients
low plasma BCAA, and especially low valine levels, have been
associated with signs of malnutrition [21] and it has been
speculated that such a relationship may also be valid for
children with renal failure [6]. However, our results demon-
strate that children with CRF may have low BCAA concentra-
tions in plasma and muscle, although they have no other
evidence of protein malnutrition.
The cause of the BCAA abnormalities in chronic uremia is far
from clear. These AA are mainly metabolized in muscle by
deamination to their keto-analogues. This is followed by oxida-
tion which is mediated via a common branched-chain keto acid
dehydrogenase complex which is rate limiting for BCAA deg-
radation. In normal and uremic rats acidosis appears to enhance
protein degradation in muscle, an effect which is thought to be
due to stimulation of BCAA decarboxylation and thereby to
cause depletion of the BCAA [22, 23]. It was recently reported
-
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Fig. 2. Relationship of ASP/DNA ratio in muscle to age in 15 ure,nic
children (•) and in 10 controls (A). The regression equation is y = 270.8
+ 1.473x. r = 0.75; P <0.001.
Values are given as mean SD. Histidine and tyrosine are regarded
as EAA.
P < 0.05
h P < 0.01
P < 0.001
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Tahle 4. Muscle free amnio acids .rmoI/liter intraceIlular water
Controls
(N= 10)
CRF
(N= 15)
that apparently well-nourished maintenance hemodialysis pa-
tients have low levels of valine in plasma and muscle [24]. The
muscle intracellular concentration of valine was significantly
correlated to the pre-dialysis standard bicarbonate concentra-
tion which varied between 20 and 25 mmol/liter, suggesting that
acidosis might enhance the metabolic degradation of valine,
With two exceptions, the uremic children had no metabolic
acidosis and no correlation was observed between serum bicar-
bonate and the concentration of the BCAA in plasma or in
muscle.
Our children with CRF had reduced plasma tyrosine concen-
trations and borderline low intracellular concentrations of ty-
rosine in muscle. The low plasma tyrosine levels in chronic
uremia reported earlier may be a consequence of a reduced
synthesis of tyrosine from phenylalanine which was due to the
inhibition of phenylalanine hydroxylase [25]. Turnover studies
indicate that the conversion of phenylalanine to tyrosine takes
place in the kidneys to a large extent, which may at least partly
explain why the tyrosine levels and the ratio of tyrosine to
phenylalanine are low in renal failure patients, for whom
tyrosine may be an indispensable AA [261.
Another typical finding (confirmed by this study) in both
11 lflñ
ARG ASP GLU GLY SER
ASN CIT GLN ORN
Fig. 3. Plasma essential and nonessential a,nino acid concentrations
in /5 ure,nic children. The data (mean SE) are given as percentages of
the normal concentrations in the age-matched control group.
adults and children with chronic renal failure is the low serine
concentration in plasma, which is commonly combined with a
high glycine level. This may result from a decreased conversion
of glycine to serine by the diseased kidneys, as demonstrated by
turnover studies in the dog and in man [27—29].
The kidney takes up citrulline and produces arginine both in
the rat and in man [29—3 1]. It has been suggested that low renal
extraction may account for the elevated plasma concentration
of citrulline in renal failure, which may be related to low
arginine synthetase in diseased kidneys. However, in our
children with CRF the arginine concentrations in plasma and
muscle were not reduced, which would suggest that the arginine
requirements were satisfied.
The accumulation of I M-HIS and 3 M-HIS in plasma and
muscle is a common finding in patients with renal failure and
may be attributed to a reduced clearance of these AA which are
not reutilized for protein synthesis but are excreted in urine
unmodified [32].
T
Essential
Histidine
Isoleucine
Leucine
Lysine
Methionjne
Phenylalanine
Threonine
Tyrosine
Valine
Non-essential
Arginine
Asparagine
Aspartic acid
Citrulline
Glutamic acid
Glutamine
Glycine
Ornithine
Serine
l-Methylhistidine +
Alanine + taurine
Ratios
Valine/glycine
Glycine/serine
Tyrosine/phenylalanine
EAA/NEAA
b b
550 225
121 26
192 45
1377 394
SI 31
91 26
782 292
147 75
285 44
979 368
515 20l
597 221
42 48
4120 1431
23428 10371
1949 665
369 89
1130 429
3-methylhistidine 141 98
14512 2742
0.16 0.07
1.78 0.46
1.77 1.11
0.06 0.01
474 111
90 31b
187 53
1496 686
43 32
86 33
593 195
109 47
231 60"
1039 649
492 182
774 465
56 SI
3943 1707
16600 8350
2735 1070"
434 172
1092 436
381 267"
17261 4260
0.10 005h
2.57 066b
1.4 0.7
0.06 0.02
C',
0
0
C.)4-0
4-.
C.)I-
ci)
a-
C')0I-4-.C0
C.)
'4-0
4-.C
a)
C.)
a)0
n.nr
HIS LEU MET THR VAL
ILE LYS PHE TYR
C
200
100
0
300
200
100
0
Total 59276 13381 59424 13351
EAA 3577 896 3302 834
NEAA 55699 1260 56122 12781
BCAA 580 101 510± 126
Values are given as mean SD.
Histidine and tyrosine are regarded as EAA.
"P < 0.05
b P < 0.01
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Fig. 4. Muscle essential and non-essential amino acid concentrations
in 15 uremic children. The data (mean SE) are given as percentages of
the normal concentrations in the age-matched control group.
Reprint requests to Alberto Canepa, M.D., Nephro/ogy Department,
Istituto Giannina Gas/mi, Largo Gero/amo Gas/mi 5, 1-16 147 Genova,
Italy.
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